
### [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174)
**Label:** Chronic Myelogenous Leukemia, BCR-ABL1 Positive

**Subclasses:** [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), 

**Class expressions from DL-Learner:**

- [NCIT:C84273](http://purl.obolibrary.org/obo/NCIT_C84273) (FGFR1 Gene Rearrangement) 55.56%
- [NCIT:C84272](http://purl.obolibrary.org/obo/NCIT_C84272) (PDGFRB Gene Rearrangement) 55.56%
- [NCIT:C84271](http://purl.obolibrary.org/obo/NCIT_C84271) (PDGFRA Gene Rearrangement) 55.56%
- [NCIT:C33331](http://purl.obolibrary.org/obo/NCIT_C33331) (Pluripotent Bone Marrow Stem Cell) 55.56%
- [NCIT:C17346](http://purl.obolibrary.org/obo/NCIT_C17346) (ABL1 Gene) 55.56%
- [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 55.56%
- [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [NCIT:C42884](http://purl.obolibrary.org/obo/NCIT_C42884) (Bone Marrow Stem Cell with Variable Lineage Potential) 55.56%
- [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [NCIT:C13456](http://purl.obolibrary.org/obo/NCIT_C13456) (Bone Marrow Stem Cell) 55.56%
- [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [CL:0008001](http://purl.obolibrary.org/obo/CL_0008001) (hematopoietic precursor cell) 55.56%
- [CL:0000988](http://purl.obolibrary.org/obo/CL_0000988) (hematopoietic cell) and [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) 55.56%
- [CL:0000548](http://purl.obolibrary.org/obo/CL_0000548) (animal cell) and [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) 55.56%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) and [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) 55.56%
- [CL:0000037](http://purl.obolibrary.org/obo/CL_0000037) (hematopoietic stem cell) and [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) 55.56%
- [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [CL:0008001](http://purl.obolibrary.org/obo/CL_0008001) (hematopoietic precursor cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 55.56%
- [CL:0000988](http://purl.obolibrary.org/obo/CL_0000988) (hematopoietic cell) and [CL:0002248](http://purl.obolibrary.org/obo/CL_0002248) (pluripotent stem cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 55.56%


